Inflexion Private Equity has announced it will divest its holdings in Lintbells, a reputed leader in pet supplements, to Vetnique Labs, which is backed by Gryphon Investors. Based in Hertfordshire, UK, Lintbells was founded nearly 20 years ago by Dr. John Howie DL and John Davies with the mission of providing scientifically backed supplements for pets. Since Inflexion’s investment in 2017, Lintbells has grown significantly, notably expanding its direct-to-consumer operations and making successful inroads in the US market through both organic growth and the acquisition of Walkin’ Pets. The divestiture results in a 5.5x return for Inflexion Enterprise Fund IV. In addition to this deal, Inflexion has proven credentials in the pet-care market with previous investments like Medivet and Kynetec. Lintbells’ ESG achievements were recently recognized with B Corp accreditation.

Private Equity, Pet Care, Healthcare,United Kingdom, United States